These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31101810)

  • 1. Skin immunisation activates an innate lymphoid cell-monocyte axis regulating CD8
    Zaric M; Becker PD; Hervouet C; Kalcheva P; Doszpoly A; Blattman N; A O' Neill L; Yus BI; Cocita C; Kwon SY; Baker AH; Lord GM; Klavinskis LS
    Nat Commun; 2019 May; 10(1):2214. PubMed ID: 31101810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lived tissue resident HIV-1 specific memory CD8
    Zaric M; Becker PD; Hervouet C; Kalcheva P; Ibarzo Yus B; Cocita C; O'Neill LA; Kwon SY; Klavinskis LS
    J Control Release; 2017 Dec; 268():166-175. PubMed ID: 29056444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge.
    Li Z; Zhang M; Zhou C; Zhao X; Iijima N; Frankel FR
    J Immunol; 2008 Feb; 180(4):2504-13. PubMed ID: 18250460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination.
    Kaufman DR; Liu J; Carville A; Mansfield KG; Havenga MJ; Goudsmit J; Barouch DH
    J Immunol; 2008 Sep; 181(6):4188-98. PubMed ID: 18768876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice.
    Maunder HE; Taylor G; Leppard KN; Easton AJ
    Vaccine; 2015 Nov; 33(48):6641-9. PubMed ID: 26529077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.
    Fitzgerald JC; Gao GP; Reyes-Sandoval A; Pavlakis GN; Xiang ZQ; Wlazlo AP; Giles-Davis W; Wilson JM; Ertl HC
    J Immunol; 2003 Feb; 170(3):1416-22. PubMed ID: 12538702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two replication-defective adenoviral vaccine vectors for the induction of immune responses to PPRV.
    Rojas JM; Moreno H; García A; Ramírez JC; Sevilla N; Martín V
    Vaccine; 2014 Jan; 32(3):393-400. PubMed ID: 24269622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
    Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
    J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.
    Belyakov IM; Ahlers JD
    Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques.
    Petitdemange C; Kasturi SP; Kozlowski PA; Nabi R; Quarnstrom CF; Reddy PBJ; Derdeyn CA; Spicer LM; Patel P; Legere T; Kovalenkov YO; Labranche CC; Villinger F; Tomai M; Vasilakos J; Haynes B; Kang CY; Gibbs JS; Yewdell JW; Barouch D; Wrammert J; Montefiori D; Hunter E; Amara RR; Masopust D; Pulendran B
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
    Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
    Lindsay RW; Darrah PA; Quinn KM; Wille-Reece U; Mattei LM; Iwasaki A; Kasturi SP; Pulendran B; Gall JG; Spies AG; Seder RA
    J Immunol; 2010 Aug; 185(3):1513-21. PubMed ID: 20610651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad cellular immunity with robust memory responses to simian immunodeficiency virus following serial vaccination with adenovirus 5- and 35-based vectors.
    Barratt-Boyes SM; Soloff AC; Gao W; Nwanegbo E; Liu X; Rajakumar PA; Brown KN; Robbins PD; Murphey-Corb M; Day RD; Gambotto A
    J Gen Virol; 2006 Jan; 87(Pt 1):139-149. PubMed ID: 16361426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal and Systemic γδ+ T Cells Associated with Control of Simian Immunodeficiency Virus Infection.
    Tuero I; Venzon D; Robert-Guroff M
    J Immunol; 2016 Dec; 197(12):4686-4695. PubMed ID: 27815422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
    Jiang JQ; Patrick A; Moss RB; Rosenthal KL
    J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.
    Luci C; Bekri S; Bihl F; Pini J; Bourdely P; Nouhen K; Malgogne A; Walzer T; Braud VM; Anjuère F
    PLoS One; 2015; 10(12):e0143224. PubMed ID: 26630176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.
    Hensel MT; Peng T; Cheng A; De Rosa SC; Wald A; Laing KJ; Jing L; Dong L; Magaret AS; Koelle DM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
    Barouch DH; Pau MG; Custers JH; Koudstaal W; Kostense S; Havenga MJ; Truitt DM; Sumida SM; Kishko MG; Arthur JC; Korioth-Schmitz B; Newberg MH; Gorgone DA; Lifton MA; Panicali DL; Nabel GJ; Letvin NL; Goudsmit J
    J Immunol; 2004 May; 172(10):6290-7. PubMed ID: 15128818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors.
    Sumida SM; Truitt DM; Kishko MG; Arthur JC; Jackson SS; Gorgone DA; Lifton MA; Koudstaal W; Pau MG; Kostense S; Havenga MJ; Goudsmit J; Letvin NL; Barouch DH
    J Virol; 2004 Mar; 78(6):2666-73. PubMed ID: 14990686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.